4.6 Review

Applications of small molecule BMP inhibitors in physiology and disease

期刊

CYTOKINE & GROWTH FACTOR REVIEWS
卷 20, 期 5-6, 页码 409-418

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2009.10.021

关键词

High throughput screen; Bone morphogenetic protein; TGF-beta; Anemia; Hepcidin; Cardiomyocyte; Embryonic stem cell; Fibrodysplasia ossificans progressiva; Bone mineral density

资金

  1. NIH [K08HL081535, K08HL079943]
  2. GSK Cardiovascular Research and Education Foundation
  3. Veterans Health Administration
  4. Center for Research in Fibrodysplasia Ossificans and Related Disorders
  5. Pulmonary Hypertension Association
  6. Massachusetts Technology Transfer Center
  7. Howard Hughes Medical Institute
  8. Harvard Stem Cell Institute
  9. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, K08HL081535] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Bone morphogenetic proteins (BMPs) provide critical signals for determining cell fate, specifying gastrulation, embryonic patterning, organogenesis, and the remodeling of diverse tissues. Recent work has suggested that in addition to coordinating pivotal events in development, BMPs may also regulate certain homeostatic physiological processes independently of effects on cell growth or differentiation. We recently described the identification of dorsomorphin, a small molecule inhibitor of BMP type I receptors which inhibits BMP signaling in preference to TGF-beta, Activin, and other ligands of the TGF-beta family. We describe a number of strategies using dorsomorphin and its derivatives as probes to assess the physiologic roles of BMP signaling. We also discuss several potential applications for small molecule BMP inhibitors, including stem cell manipulation, and the therapeutic modification of bone remodeling, heterotopic ossification, and iron homeostasis. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据